Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ P2Y1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ 347200

Description
P2Y1 Polyclonal Antibody for Western Blot, ELISA
P2Y1 is a Purinergic Receptor that causes a change in platelet shape and potentially leads to platelet aggregation by binding ADP, which results in the mobilization of intracellular calcium ions via activation of phospholipase C. This receptor also mediates the release of the relaxing factor nitric oxide and may be involved in the modulation of neuronal signal transmission. P2Y1 has been reported to be expressed in tissues throughout the body, particularly brain. ESTs have been isolated from human embryo, lung, and placenta libraries.
Specifications
P2Y1 | |
Polyclonal | |
Unconjugated | |
P2ry1 | |
ADP receptor; ATP receptor; P2 purinoceptor subtype Y1; P2 purinoreceptor subclass 2Y; P2RY1; P2y; P2Y ATP receptor 1; P2Y purinoceptor 1; P2Y1; P2Y1 receptor; p2y1r; p2y-1-r; platelet ADP receptor; Purinergic receptor; purinergic receptor P2Y, G-protein coupled 1; purinergic receptor P2Y, G-protein coupled, 1; purinergic receptor P2Y1; Purinoceptor p2y1; Purinoceptor p2yr1 | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
18441, 25265, 5028 | |
-20°C | |
Liquid |
ELISA, Western Blot | |
0.25 mg/mL | |
PBS with 0.1% sodium azide; pH 7.4 | |
P47900, P49650, P49651 | |
P2ry1 | |
Synthetic peptide derived from the intracellular C-terminal region of the human P2Y1 receptor protein. | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction